Rubella Virus IgM Hybrid Human Monoclonal Antibody

Ref. 3D-BM1361

Informations sur le produit

• Nom: Rubella Virus IgM Hybrid Human Monoclonal Antibody

Description

The rubella virus is an infectious disease and a member of the matonaviridae family. This virus commonly causes mild symptoms such as a rash, swollen lymph nodes, sore throat and fever in humans. Although complications such as nerve inflammation, encephalitis and bleeding problems may occur. Interestingly patients with the virus are infectious one week before and after the rash appears.
Characterized disease state sera are critical components in the development and manufacture of diagnostic tests. However, sourcing of these sera is complicated, time-consuming, and sometimes suitable material is not available at all. Cymit Quimica have the Rubella Virus IgM Hybrid Human Monoclonal Antibody which is highly specific, reliable sourced and is produced under ISO 13485 and exhibits lot-to-lot consistency.
This Rubella Virus IgM Hybrid Human Monoclonal Antibody has been produced in mice genetically modified to express human IgM heavy chain constant region. They are then concentrated and spiked into an IgG depleted and delipidised human serum matrix which ensures that the final product is as close as possible to the natural disease state IgM positive human plasma. As part of the selection process for each antibody multiple clones were analyzed by commercially available IgM assays and the clones with the most reactivity were selected for commercialization. Testing in both ELISA and bead-based applications shows the products behave in an almost identical manner as the natural source.

• Marque: Biosynth